1. Home
  2. KLTOW vs ONTO Comparison

KLTOW vs ONTO Comparison

Compare KLTOW & ONTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • ONTO
  • Stock Information
  • Founded
  • KLTOW N/A
  • ONTO 1940
  • Country
  • KLTOW United States
  • ONTO United States
  • Employees
  • KLTOW 3
  • ONTO N/A
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • ONTO Industrial Machinery/Components
  • Sector
  • KLTOW Health Care
  • ONTO Industrials
  • Exchange
  • KLTOW Nasdaq
  • ONTO Nasdaq
  • Market Cap
  • KLTOW N/A
  • ONTO 4.6B
  • IPO Year
  • KLTOW 2022
  • ONTO N/A
  • Fundamental
  • Price
  • KLTOW $0.25
  • ONTO $103.40
  • Analyst Decision
  • KLTOW
  • ONTO Strong Buy
  • Analyst Count
  • KLTOW 0
  • ONTO 7
  • Target Price
  • KLTOW N/A
  • ONTO $141.67
  • AVG Volume (30 Days)
  • KLTOW N/A
  • ONTO 1.2M
  • Earning Date
  • KLTOW N/A
  • ONTO 08-07-2025
  • Dividend Yield
  • KLTOW N/A
  • ONTO N/A
  • EPS Growth
  • KLTOW N/A
  • ONTO 57.20
  • EPS
  • KLTOW N/A
  • ONTO 4.42
  • Revenue
  • KLTOW N/A
  • ONTO $1,025,082,000.00
  • Revenue This Year
  • KLTOW N/A
  • ONTO $3.41
  • Revenue Next Year
  • KLTOW N/A
  • ONTO $8.13
  • P/E Ratio
  • KLTOW N/A
  • ONTO $23.38
  • Revenue Growth
  • KLTOW N/A
  • ONTO 21.23
  • 52 Week Low
  • KLTOW N/A
  • ONTO $85.88
  • 52 Week High
  • KLTOW N/A
  • ONTO $238.93
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW N/A
  • ONTO 56.03
  • Support Level
  • KLTOW N/A
  • ONTO $97.91
  • Resistance Level
  • KLTOW N/A
  • ONTO $103.03
  • Average True Range (ATR)
  • KLTOW 0.00
  • ONTO 3.39
  • MACD
  • KLTOW 0.00
  • ONTO 1.19
  • Stochastic Oscillator
  • KLTOW 0.00
  • ONTO 94.10

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About ONTO Onto Innovation Inc.

Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.

Share on Social Networks: